Oral GLP-1 Medicine Strategy: Fondo Growth and International Expansion

This content outlines the strategic rollout of oral GLP-1 medicines, highlighting strong early adoption rates and government coverage initiatives for seniors. It details the production efficiency in Texas and the plan to expand into international markets to meet global demand.

Key topics covered include:
- Current performance metrics for oral GLP-1 categories
- Impact of federal government coverage on senior adoption
- Manufacturing strategy centered in Texas with global distribution
- Timeline for entering four to five new international markets

The discussion provides insights into pharmaceutical supply chain strategies and market expansion tactics for emerging drug categories.